UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: (Date of earliest event reported) October 10, 2018
UNITED CANNABIS CORPORATION
----------------------------------------
(Exact name of registrant as specified in charter)
Colorado
-------------------------------------------------
(State or other Jurisdiction of Incorporation or Organization)
1600 Broadway, Suite 1600
000-54582 Denver, CO 80202 46-5221947
---------------------- ------------------------------ ---------------------
(Commission File Number) (Address of Principal Executive (IRS Employer
Offices and Zip Code) Identification Number)
(303) 386-7321
-------------------------------------------------
(Registrant's telephone number, including area code)
N/A
-----------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
CFR 240.14a-12(b))
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. [ ]
1
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On October 10, 2018 the Company issued a press release, attached as Exhibit
99, providing guidance on third quarter operating results.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
Number Description
99 October 10, 2018 Press Release
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
UNITED CANNABIS CORPORATION
Dated: October 24, 2018 By: Chad Ruby
-------------------------------
Chad Ruby
Chief Operating Officer
3
EXHIBIT 99
UNITED CANNABIS CORPORATION GIVES GUIDANCE ON THIRD QUARTER RESULTS
Company To Report $2 Million In Revenue For The Third Quarter,
Forecasting $10 Million For the Year
Denver, CO October 10, 2018 - United Cannabis Corporation (OTCQB: CNAB) (the
"Company" or "United Cannabis") today provided preliminary, unaudited figures on
revenues for the third quarter 2018 and offered guidance for the year.
Revenues for the third quarter 2018 are $2 million, and approximately $4.2 for
the year to date.
Although consistent with the second quarter, the results were somewhat impacted
by a seasonal shortage of raw materials. The current harvest season has
alleviated the seasonal shortage and, thus, Management believes the Company is
still on track to report a minimum of $10 million in revenue for 2018.
The third quarter 2018 revenues amount has not be subjected to an unaudited
review by the Company's auditors, and may be subject to change upon the
completions of such unaudited review
About United Cannabis Corporation
United Cannabis Corporation is dedicated to the development of phyto-therapeutic
based products supported by patented technologies for the pharmaceutical,
medical, and industrial markets. The Company has long advocated the application
of cannabinoids for medical applications and is building a platform for
designing targeted therapies to increase the quality of life for patients around
the world. The Company's products are patent protected, first in class medicines
with applications to a global market. United Cannabis trades on the OTCQB under
the symbol CNAB.
For further information, please visit www.unitedcannabis.us.
Contact: Staff@UnitedCannabis.us
Phone: 303-386-7321
Certain statements in this news release may contain forward-looking information
within the meaning of Rule 175 under the Securities Act of 1933, are subject to
Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe
harbors created by those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements regarding
potential future plans and objectives of the company, are forward-looking
statements that involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and other results and further events
could differ materially from those anticipated in such statements. Future events
and actual results could differ materially from those set forth in, contemplated
by, or underlying the forward-looking statements.
